Accordingly, MM patients presented approximately 1.5- to three-fold increase in the expression levels of OGT and CDC27 in both the training set and the test set in MM patients when compared with the healthy individuals, respectively (Fig. 1e). The gene discussed is OGT; the disease is Miyoshi myopathy.